Spending Bill Addresses Conflict Waivers, Sunscreen Monograph
This article was originally published in The Tan Sheet
Executive Summary
FDA will be required to publicly disclose the rationale behind any advisory committee conflict of interest waivers under an amendment to the Senate version of the agency's spending bill
You may also be interested in...
EU Sheds Light On Recommended Sunscreen Labeling Options
Sunscreen protection levels would be ranked in four categories - low, medium, high or very high - on product labeling under a proposal by the European Commission
EU Sheds Light On Recommended Sunscreen Labeling Options
Sunscreen protection levels would be ranked in four categories - low, medium, high or very high - on product labeling under a proposal by the European Commission
EU Sheds Light On Recommended Sunscreen Labeling Options
Sunscreen protection levels would be ranked in four categories - low, medium, high or very high - on product labeling under a proposal by the European Commission